Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 12
Original Research
A Cost per Responder Model for Abatacept versus Adalimumab Among Rheumatoid Arthritis Patients with Seropositivity
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,910 | Dovepress* | 4,605+ | 877 | 5,482 | |
| PubMed Central* | 305 | 106 | 411 | ||
| Totals | 4,910 | 983 | 5,893 | ||
| *Since 15 October 2020 | |||||
View citations on PubMed Central and Google Scholar